|
|
|
Volumn 8, Issue 6 Suppl 1, 2001, Pages
|
|
Ovarian cancer as a chronic disease: a new treatment paradigm. Highlights of a roundtable discussion.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BRIDGED COMPOUND;
CA 125 ANTIGEN;
PLATINUM;
TAXANE;
TAXOID;
TUMOR MARKER;
ARTICLE;
CHRONIC DISEASE;
DRUG RESISTANCE;
FEMALE;
FOLLOW UP;
HUMAN;
METHODOLOGY;
OVARY TUMOR;
PALLIATIVE THERAPY;
RECURRENT DISEASE;
REMISSION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRIDGED COMPOUNDS;
CA-125 ANTIGEN;
CHRONIC DISEASE;
DRUG RESISTANCE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
OVARIAN NEOPLASMS;
PALLIATIVE CARE;
PLATINUM;
RECURRENCE;
REMISSION INDUCTION;
TAXOIDS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 1842868580
PISSN: 10732748
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
